Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275691 · ClinicalTrials.gov registry record
Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 867
- Enrollment target
NCT00275691: Completed study, sponsored by Mayo Clinic.
NCT00275691 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 867 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275691 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 867 participants
- Enrollment target
Study Summary
Community acquired pneumonia(CAP) is a common cause of morbidity and mortality. The diagnosis of CAP from the microbiology perspective has been challenging. Recent reports suggest the utility of real-time PCR for rapid and accurate diagnoses of these pathogens. Real-Time PCR tests, using the LightCycler instrument, will be performed on excess or additional specimens after extraction of nucleic acid.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 867 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275691
The ClinicalTrials.gov registry entry for NCT00275691 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 867 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00275691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00275691 about?
NCT00275691 is a clinical study titled "Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR". Community acquired pneumonia(CAP) is a common cause of morbidity and mortality. The diagnosis of CAP from the microbiology perspective has been challenging. Recent reports suggest the utility of real-time PCR for rapid and accurate diagnoses of these pathogens. Real-Time PCR tests, using the LightCy...
What is the current status of trial NCT00275691?
This trial is currently completed. The enrollment target is 867 participants. The study started on 2005-10. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00275691?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.